Clinical Trial

A Study of ATG-201 in Adult Participants With Autoimmune Diseases

Study acronym: ATTRACT
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a phase I, open-label study of ATG-201 in participants with autoimmune diseases.
Trial Details
NCT Number NCT07732309
Lead Sponsor Antengene Biologics Limited
Conditions Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease
Enrollment 149 participants
Start Date 2026-09-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-28